Said Saim

Chief Tech/Sci/R&D Officer at EYEPOINT PHARMACEUTICALS, INC.

66 year

Health Technology

Consumer Services

Profile

Said Saim is currently working as the Chief Technology Officer & Senior VP at EyePoint Pharmaceuticals, Inc. Prior to his current position, he worked as the Senior Director-Pharmaceutical Development at Collegium Pharmaceutical, Inc. from 2008 to 2013.
He also held the position of Principal Scientist at Boehringer Ingelheim Pharmaceuticals, Inc. and Assistant Research Professor at Higuchi Bioscience Center.
Dr. Saim completed his graduate and doctorate degrees at the University of Kansas.

Said Saim active positions

Companies	Position	Start
EYEPOINT PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	09/06/2019

All active positions of Said Saim

Former positions of Said Saim

Companies	Position	End
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Corporate Officer/Principal	-
Higuchi Bioscience Center	Corporate Officer/Principal	-
COLLEGIUM PHARMACEUTICAL, INC.	Corporate Officer/Principal	-

See the detail of Said Saim's experience

Training of Said Saim

University of Kansas

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Said Saim's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
COLLEGIUM PHARMACEUTICAL, INC.	Health Technology
EYEPOINT PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology
Higuchi Bioscience Center